Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.190
+0.150 (4.93%)
At close: Apr 28, 2026, 4:00 PM EDT
3.200
+0.010 (0.31%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Tvardi Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 8.74 | 4.46 | 2.8 | 2.73 |
| Research & Development | 18.01 | 23.65 | 15.87 | 18.47 |
| Operating Expenses | 26.75 | 28.11 | 18.67 | 21.19 |
| Operating Income | -26.75 | -28.11 | -18.67 | -21.19 |
| Interest Expense | - | - | - | -0 |
| Interest & Investment Income | 1.38 | 0.75 | 1.32 | 0.65 |
| Other Non Operating Income (Expenses) | 7.16 | -2.04 | - | - |
| Pretax Income | -18.21 | -29.4 | -17.35 | -20.54 |
| Net Income | -18.21 | -29.4 | -17.35 | -20.54 |
| Net Income to Common | -18.21 | -29.4 | -17.35 | -20.54 |
| Shares Outstanding (Basic) | 7 | 3 | 6 | 6 |
| Shares Outstanding (Diluted) | 8 | 3 | 6 | 6 |
| Shares Change (YoY) | 202.35% | -59.64% | 0.09% | - |
| EPS (Basic) | -2.46 | -11.42 | -2.72 | -3.22 |
| EPS (Diluted) | -3.26 | -11.42 | -2.72 | -3.22 |
| Free Cash Flow | -23.5 | -18.31 | -21.04 | -17.92 |
| Free Cash Flow Per Share | -3.02 | -7.11 | -3.30 | -2.81 |
| EBITDA | -26.65 | -28.01 | -18.57 | -21.11 |
| D&A For EBITDA | 0.1 | 0.1 | 0.1 | 0.09 |
| EBIT | -26.75 | -28.11 | -18.67 | -21.19 |
Source: S&P Capital IQ. Standard template.
Financial Sources.